UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~May~~July 1224, 2008

IMCLONE SYSTEMS INCORPORATED

(Exact name of registrant as specified in its charter)

Delaware		0-19612		04-2834797
(State or other jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

180 Varick Street

New York, New York 10014

(Address of principal executive offices) (Zip Code)

(212) 645-1405

(Registrant's telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 52.02. ~~Departure~~Results of ~~Directors~~Operations orand ~~Principal~~Financial ~~Officers; Election of Directors; Appointment of Principal Officers~~Condition.

OnImClone ~~May 12,~~Systems ~~2008,~~Incorporated ~~John~~announced E.today ~~Celentano,~~its ~~age~~financial ~~48,~~results ~~was~~for ~~named a director of ImClone Systems Incorporated (~~the ~~“Company”).~~three ~~Mr. Celentano is a Senior~~month ~~Vice~~period ~~President,~~ended ~~Strategy~~June ~~and Productivity Transformation at Bristol-Myers Squibb Company (“BMS”)~~30, ~~and has served in such capacity since March~~ 2008. ~~Prior~~A tocopy ~~his current position, Mr. Celentano served in a number~~ of ~~positions~~ atthe ~~BMS,~~press ~~including~~release ~~President,~~is ~~Health~~attached ~~Care Group from December 2005 to February 2008 and~~ as ~~President, Canada and Latin America from April 2002 to~~ ~~November 2005~~Exhibit 99.1 ~~Mr. Celentano was appointed a director pursuant~~ to ~~the Stockholders~~this ~~Agreement between the Company and BMS dated as of September 19, 2001~~report.

The press release is being furnished pursuant to Item 2.02, and the information contained therein shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liabilities under that Section. Furthermore, the information in Exhibit 99.1 shall not be deemed to be incorporated by reference into the filings of ImClone Systems Incorporated under the Securities Act of 1933.

ITEM 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description

99.1		Press Release of ImClone Systems Incorporated dated July 24, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	IMCLONE SYSTEMS INCORPORATED (Registrant)
	By:	/s/ Gregory T. Mayes
Dated: July 24, 2008	By:	/s/ Gregory T. Mayes
Dated: May 16, 2008		Gregory T. Mayes Vice President and Interim General Counsel
		Gregory T. Mayes Vice President and Interim General Counsel

Filing Compare · IMCLONE SYSTEMS INC